In 2024, there were a total of 7,146 deaths in Canada due to opioid overdose, with around 74 percent of these deaths involving fentanyl. This statistic shows the share of deaths from opioid overdose in Canada from 2016 to 2024 that involved select drugs.

A listing of each accidental death associated with drug overdose in Connecticut from 2012 to 2024. A "Y" value under the different substance columns indicates that particular substance was detected. Data are derived from an investigation by the Office of the Chief Medical Examiner which includes the toxicity report, death certificate, as well as a scene investigation. The “Morphine (Not Heroin)” values are related to the differences between how Morphine and Heroin are metabolized and therefor detected in the toxicity results. Heroin metabolizes to 6-MAM which then metabolizes to morphine. 6-MAM is unique to heroin, and has a short half-life (as does heroin itself). Thus, in some heroin deaths, the toxicity results will not indicate whether the morphine is from heroin or prescription morphine. In these cases the Medical Examiner may be able to determine the cause based on the scene investigation (such as finding heroin needles). If they find prescription morphine at the scene it is certified as “Morphine (not heroin).” Therefor, the Cause of Death may indicate Morphine, but the Heroin or Morphine (Not Heroin) may not be indicated. “Any Opioid” – If the Medical Examiner cannot conclude whether it’s RX Morphine or heroin based morphine in the toxicity results, that column may be checked

In King County, Washington, the highest share of drug overdose deaths between 2019 and 2024 occurred in houses that were privately owned or rented. However, in 2023, around 24 percent of drug overdose deaths occurred in a location not meant for human habitation or emergency shelter. This statistic depicts the distribution of drug overdose deaths in King County, Washington between 2019 and 2024, by housing status.

A. SUMMARY This dataset includes unintentional drug overdose death rates by race/ethnicity by year. This dataset is created using data from the California Electronic Death Registration System (CA-EDRS) via the Vital Records Business Intelligence System (VRBIS). Substance-related deaths are identified by reviewing the cause of death. Deaths caused by opioids, methamphetamine, and cocaine are included. Homicides and suicides are excluded. Ethnic and racial groups with fewer than 10 events are not tallied separately for privacy reasons but are included in the “all races” total. Unintentional drug overdose death rates are calculated by dividing the total number of overdose deaths by race/ethnicity by the total population size for that demographic group and year and then multiplying by 100,000. The total population size is based on estimates from the US Census Bureau County Population Characteristics for San Francisco, 2022 Vintage by age, sex, race, and Hispanic origin. These data differ from the data shared in the Preliminary Unintentional Drug Overdose Death by Year dataset since this dataset uses finalized counts of overdose deaths associated with cocaine, methamphetamine, and opioids only. B. HOW THE DATASET IS CREATED This dataset is created by copying data from the Annual Substance Use Trends in San Francisco report from the San Francisco Department of Public Health Center on Substance Use and Health. C. UPDATE PROCESS This dataset will be updated annually, typically at the end of the year. D. HOW TO USE THIS DATASET N/A E. RELATED DATASETS Overdose-Related 911 Responses by Emergency Medical Services Preliminary Unintentional Drug Overdose Deaths San Francisco Department of Public Health Substance Use Services F. CHANGE LOG 12/16/2024 - Updated with 2023 data. Asian/Pacific Islander race/ethnicity group was changed to Asian. 12/16/2024 - Past year totals by race/ethnicity were revised after obtaining accurate race/ethnicity for some decedents that were previously marked as “unknown” race/ethnicity.

We collect data and report statistics on opioid, stimulant, and other substance use and their impact on health and well-being.

In 2024, there were a total of ***** deaths in Canada due to opioid overdose. Of this total, around ***** deaths, or ** percent, were accidental overdose deaths. This statistic shows the number of deaths from opioid overdose in Canada from 2016 to 2024, by manner of death.

This dashboard provides in-depth analysis surrounding events and characteristics of individuals who experienced non-fatal and/or fatal opioid overdoses in the District of Columbia. It includes data on ambulance transports for overdoses, fatalities, naloxone distribution, harm reduction efforts and the results of our used syringe testing. Data is aggregated at the neighborhood and ward levels. Data on fatal opioid overdoses will include deaths from 2021-2024. Data on non-fatal opioid overdoses will include incidents from 2021-2024. Note: Fatal opioid overdose data are delayed by approximately 90 days due to toxicological testing.

In 2024, there were a total of ***** deaths in Canada due to opioid overdose, with around ** percent of deaths occurring among males. This statistic shows the distribution of deaths from opioid overdose in Canada from 2016 to 2024, by gender.

According to Cognitive Market Research, the Global Opioids Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

  The global opioid market will expand significantly by XX% CAGR between 2024 and 2030.
  The Pain Relief segment accounts for the largest market share and is anticipated to a healthy growth over the approaching years.
  The hospital pharmacies had a market share of about XX% in 2023.
  The Extended Release /Long-Acting Opioids holds the largest share and is expected to grow in the coming years as well.
  The injectable segment is the market's largest contributor and is anticipated to expand at a CAGR of XX% during the projected period.
  The oxycodone segment holds the largest share and is expected to grow in the coming years as well.
  North America region dominated the market and accounted for the highest revenue of XX% in 2023 and it is projected that it will grow at a CAGR of XX% in the future.

Market Dynamics of the Opioids

Rising prevalence of chronic pain conditions globally

The increased prescription of painkillers during post-operative procedures and an increase in patients with terminally chronic pain or diseases including HIV, and severe cough brought on by lung infections are two causes that are anticipated to increase opioid use as a pain reliever. Chronic pain affects an estimated 20% of the global population, with conditions such as arthritis, cancer, and lower back pain contributing to the growing demand for effective pain management solutions. In the past, it resulted in a demand surge for opioids and boosted growth. Another factor for the growth of the opioid drug market is the spike in the number of surgeries. According to the National Health Interview Survey (NHIS) conducted by the Centers for Disease Control and Prevention (CDC) in 2019, the prevalence of high-impact chronic pain in the United States was 7.4 percent.

(Source-https://www.cdc.gov/nchs/data/databriefs/db390-H.pdf)

The aging population’s vulnerability is at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Declining fertility and mortality rates are some factors contributing to the geriatric population's rise. The impact of chronic pain increases with age and is highest among adults aged 65 years and above. Therefore, the rising geriatric population is anticipated to increase the demand for opioid drugs to manage chronic pain. According to the World Health Organization (WHO), the geriatric population increased from 1.0 million in 2020 to 1.4 million in 2021.

(Source-https://www.who.int/news-room/fact-sheets/detail/ageing-and-health)

Opioid addiction and its side effects pose significant challenges to the market

One of the major challenges for this market is the high potential for abuse and addiction, physicians have scaled back their pain management prescriptions, decreasing global scales. The rising prevalence of opioid abuse is expected to stifle market growth, as practitioners are hesitant to prescribe opioids as pain relievers. The patient may become tolerant and need more and more drugs to achieve the effect of smoothing the pain. Moreover, using opioids for an extended period can develop a dependency, and after leaving the drug, the patient may suffer from withdrawal symptoms such as anxiety, irritability, drug cravings, tremors (shaking), and others. The heightened regulatory scrutiny has resulted in stricter guidelines for prescribing opioids, impacting accessibility for patients in genuine need of pain relief. Regulatory changes often aim to strike a balance between ensuring access for patients and preventing misuse. The forecasted period illustrates a decrease in the opioid market growth due to the adversities and the negative effects of opioids. Researchers and experts have considered this and are making constant efforts to reduce and minimize the negative side effects of opioids. As per the record, drug overdose in the year 2018, had 657 deaths.

(Source-https://www.mass.gov/doc/opioid-related-overdose-deaths-among-ma-residents-august-2018/download)

Furthermore, the Millennium Health's Signals report (2020) revealed that there was a rise in non-prescribe...

In 2024, around ** percent of opioid overdose deaths in Canada involved people aged 30 to 39 years. This statistic shows the distribution of accidental apparent deaths from opioid overdose in Canada in 2024, by age.

In 2024, around 80 percent of accidental opioid overdose deaths in British Columbia involved only non-pharmaceutical opioids. In comparison, 43 percent of accidental opioid overdose deaths in New Brunswick involved only pharmaceutical opioids. This statistic shows the distribution of deaths from opioid overdose in Canada in 2024, by province and opioid origin.

This dataset is deprecated and will be removed by the end of the calendar year 2024. Updated on 8/18/2024 Drug and alcohol-related Intoxication death data is prepared using drug and alcohol intoxication data housed in a registry developed and maintained by the Vital Statistics Administration (VSA) of the Maryland Department of Health and Mental Hygiene (DHMH). The methodology for reporting on drug-related intoxication deaths in Maryland was developed by VSA with assistance from the DHMH Alcohol and Drug Abuse Administration, the Office of the Chief Medical Examiner (OCME) and the Maryland Poison Control Center. Assistance was also provided by authors of a 2008 Baltimore City Health Department report on intoxication deaths. Data in this table is by incident location, where the death occurred, rather than by county of residence.

Deaths related to drug poisoning in England and Wales by cause of death, sex, age, substances involved in the death, geography and registration delay.

In 2023, around 72,776 people in the United States died from a drug overdose that involved fentanyl. This was the second-highest number of fentanyl overdose deaths ever recorded in the United States, and a significant increase from the number of deaths reported in 2019. Fentanyl overdoses are now the driving force behind the opioid epidemic, accounting for the majority of overdose deaths in the United States. What is fentanyl? Fentanyl is an extremely potent synthetic opioid similar to morphine, but more powerful. It is a prescription drug but is also manufactured illegally and is sometimes mixed with other illicit drugs such as heroin and cocaine, often without the user’s knowledge. The potency of fentanyl makes it very addictive and puts users at a high risk for overdose. Illegally manufactured fentanyl has become more prevalent in the United States in recent years, leading to a huge increase in drug overdose deaths. In 2022, the rate of drug overdose death involving fentanyl was 22.7 per 100,000 population, compared to a rate of just one per 100,000 population in the year 2013. Fentanyl overdoses by gender and race/ethnicity As of 2022, the rate of drug overdose deaths involving fentanyl in the United States is over two times higher among men than women. Rates of overdose death involving fentanyl were low for both men and women until around the year 2014 when they began to quickly increase, especially for men. In 2022, there were around 19,880 drug overdose deaths among women that involved fentanyl compared to 53,958 such deaths among men. At that time, the rate of fentanyl overdose deaths was highest among non-Hispanic American Indian or Alaska Natives and lowest among non-Hispanic Asians. However, from the years 2014 to 2018, non-Hispanic whites had the highest fentanyl overdose death rates.

The graph illustrates the number of deaths from fentanyl in the United States from 1999 to 2022. The x-axis represents the years, spanning from '99 to '22, while the y-axis displays the annual number of fentanyl-related fatalities. Over this 24-year period, deaths rise dramatically from 730 in 1999 to a peak of 73,838 in 2022. Notable milestones include an increase to 1,742 deaths in 2005, a significant jump to 9,580 in 2015, and a sharp escalation to 70,601 deaths by 2021. The data reveals a consistent and severe upward trend in fentanyl-related deaths, particularly accelerating in the mid-2010s. This information is presented in a line graph format, effectively highlighting the dramatic increase in fatalities due to fentanyl across the United States over the specified years.

In 2024, around 74 percent of opioid overdose deaths in the province of British Columbia were male. This statistic shows the distribution of deaths from accidental apparent opioid overdose in Canadian provinces in 2024, by gender.

To: State, territorial, tribal, and local policymakers and administrators of agencies and programs focused on child, youth, and family health and well-being Dear Colleagues, Thank you for your work to support children, youth, and families. Populations served by Administration for Children and Families (ACF)-funded programs — including victims of trafficking or violence, those who are unhoused, and young people and families involved in the child welfare system — are often at particularly high risk for substance use and overdose. A variety of efforts are underway at the federal, state, and local levels to reduce overdose deaths. These efforts focus on stopping drugs from entering communities, providing life-saving resources, and preventing drug use before it starts. Initiatives across the country are already saving lives: the overdose death rate has declined over the past year but remains too high at 32.6 per 100,000 individuals. Fentanyl, a powerful synthetic opioid, raises the risk of overdose deaths because even a tiny amount can be deadly. Young people are particularly at risk for fentanyl exposure, driven in part by widespread availability of counterfeit pills containing fentanyl that are marketed to youth through social media. While overdose deaths among teens have recently begun to decline, there were 6,696 deaths among adolescents and young adults in 2022 (the latest year with data available)[1], making unintentional drug overdose the second leading cause of death for youth ages 15—19 and the first leading cause of death among young adults ages 20-24.[2] Often these deaths happen with others nearby and can be prevented when opioid overdose reversal medications, like naloxone, are administered in time. CDC’s State Unintentional Drug Overdose Reporting System dashboard shows that in all 30 jurisdictions with available data, 64.7% of drug overdose deaths had at least one potential opportunity for intervention.[3] Naloxone rapidly reverses an overdose and should be given to any person who shows signs of an opioid overdose or when an overdose is suspected. It can be given as a nasal spray. Studies show that naloxone administration reduces death rates and does not cause harm if used on a person who is not overdosing on opioids. States have different policies and regulations regarding naloxone distribution and administration. Forty-nine states and the District of Columbia have Good Samaritan laws protecting bystanders who aid at the scene of an overdose.[4] ACF grant recipients and partners can play a critical role in reducing overdose deaths by taking the following actions: Stop Overdose Now (U.S. Centers for Disease Control and Prevention) Integrating Harm Reduction Strategies into Services and Supports for Young Adults Experiencing Homelessness (PDF) (ACF) Thank you for your dedication and partnership. If you have any questions, please contact your local public health department or state behavioral health agency. Together, we can meaningfully reduce overdose deaths in every community. /s/ Meg Sullivan Principal Deputy Assistant Secretary [1] Products - Data Briefs - Number 491 - March 2024 [2] WISQARS Leading Causes of Death Visualization Tool [3] SUDORS Dashboard: Fatal Drug Overdose Data | Overdose Prevention | CDC [4] Based on 2024 report from the Legislative Analysis and Public Policy Association (PDF). Note that the state of Kansas adopted protections as well following the publication of this report. Metadata-only record linking to the original dataset. Open original dataset below.

This brief communicates trends in Nitazenes from 2019-2022, a group of powerful illicit opioids that have been linked to overdose deaths in TN.

This dataset is deprecated and will be removed by the end of the calendar year 2024. Updated on 8/18/2024

Data sources: heroin overdose deaths/infant mortality-Vital Statistics Administration; lead-Medicaid; HIV diagnoses-Prevention and Health Promotion Administration; and immunizations-National Immunization Survey.

A. SUMMARY This dataset comes from the San Francisco Emergency Medical Services Agency and includes all opioid overdose-related 911 calls responded to by emergency medical services (ambulances). The purpose of this dataset is to show how many opioid overdose-related 911 calls the San Francisco Fire Department and other ambulance companies respond to each week. This dataset is based on ambulance patient care records and not 911 calls for service data. B. HOW THE DATASET IS CREATED The San Francisco Fire Department and other ambulance companies send electronic patient care reports to the California Emergency Medical Services Agency for all 911 calls they respond to. The San Francisco Emergency Medical Services Agency (SF EMSA) has access to the state database that includes all reports for 911 calls in San Francisco County. In order to identify overdose-related calls that resulted in an emergency medical service (or ambulance) response, SF EMSA filters the patient care reports based on set criteria used in other jurisdictions called The Rhode Island Criteria. These criteria filter calls to only include those calls where EMS documented that an opioid overdose was involved and/or naloxone (Narcan) was administered. Calls that do not involve an opioid overdose are filtered out of the dataset. Calls that result in a patient death on scene are also filtered out of the dataset. This dataset is created by copying the total number of calls each week when the state makes this data available. C. UPDATE PROCESS Data is generally available with a 24-hour lag on a weekly frequency but the exact lag and update frequency is based on when the State makes this data available. D. HOW TO USE THIS DATASET This dataset includes the total number of calls a week. The week starts on a Sunday and ends on the following Saturday. This dataset will not match the Fire Department Calls for Service dataset, as this dataset has been filtered to include only opioid overdose-related 911 calls based on electronic patient care report data. Additionally, the Fire Department Calls for Service data are primarily based on 911 call data (i.e. calls triaged and recorded by San Francisco’s 911 call center) and not the finalized electronic patient care reports recorded by Fire Department paramedics. E. RELATED DATASETS Fire Department Calls for Service San Francisco Department of Public Health Substance Use Services Unintentional Overdose Death Rates by Race/Ethnicity Preliminary Unintentional Drug Overdose Deaths F. CHANGE LOG 1/17/2024 - updated date/time fields from Coordinated Universal Time (UTC) to Pacific Time (PT) which caused a slight change in historic case counts by week.